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The nervous system is divided into the central nervous system (CNS) 
and the peripheral nervous system (PNS). The brain and the spinal cord are 
the primary component of the CNS. The PNS is formed by nerves and ganglia 
that connect organs and extremities. The primary function of the PNS is to 
send information to the CNS where it is processed to coordinate the activity of 
the entire body. The PNS connects the CNS to the limbs and organs and builds 
up a communication system going back and forth between the brain and the 
rest of the body. Information is transmitted and interpreted by a complex 
network of nerve cells in the brain, which are known as neurons. When 
neurons are electrically excitable specialized connections called synapses 
enable the transfer of information between neurons (Kandel, Schwartz et al. 
2000, Hammond 2001). 
 
The Chemical Synapse 
Neurons are connected to each other by electrical and chemical 
synapses. Electrical synapses are linked by gap junctions which permit 
bidirectional passive flow of current between the pre- and postsynaptic 
membrane. The extracellular synaptic distance is very small, around 3 nm and 
the transmission speed of the signal is about ten times faster than chemical 
synapses (Larsen 1977). Electrical transmission is known to occur in the 
retina, inferior olive and the olfactory bulb. Furthermore, electrical synapses 
are more abundant in invertebrates and cold-blooded vertebrates (Hormuzdi, 
Filippov et al. 2004, Pereda 2014). 
Chemical transmission occurs between synaptic terminals from axons 
and the dendrite or soma of a second neuron, muscle fiber or gland cell 
(Pereda 2014). At these synapses, the electrical signal is transmitted along an 
axon by voltage-gated ion channels to the axon terminal, where the action 
potential (AP) leads to the release of neurotransmitter (NT) into the synaptic 
cleft. The release of the NT is the chemical signal. The released NTs bind to 




channels on the membrane. This causes an influx of ions across the 
membrane or modulates the production of chemical messengers. This influx 
changes the postsynaptic membrane potential, which allows the regeneration 
of an electrical signal. For a functional network this process needs to be rapid, 
reliable and highly adaptable (Kandel, Schwartz et al. 2000, Hammond 2001). 
In this work we will focus mainly on the process of presynaptic NT release 
which will be described in more detail in the following paragraph. 
 
The Synaptic Vesicle Cycle 
In the presynaptic terminal, NTs are stored in synaptic vesicles (SVs) 
that can fuse with the plasma membrane to release their content. The precise 
timing of the release is very important for normal synaptic function. 
Furthermore, during neuronal activity efficient endocytic membrane retrieval is 
required to keep the membrane surface area constant and reformation of SVs 
is needed to replenish the SV pool (Sudhof and Jahn 1991, Kononenko, 
Puchkov et al. 2014). Hence, the SVs undergo a trafficking cycle (Figure 1) 
(Sudhof 2004).  
Before SV exocytosis can occur, SVs need to be ready for fusion with 
the plasma membrane. The fusion of the SVs occurs in a specialized area of 
the presynaptic plasma membrane, the active zone. The active zone can be 
identified under the electron microscope directly at the synaptic cleft. This 
structure results from the accumulation of cytoskeleton-associated proteins 
forming the cytomatrix of the active zone. Different non-membrane proteins at 
the active zone create a homogeneous single complex by binding to each 
other. These are multidomain proteins, namely Munc13s and RIMs (Brose, 
Hofmann et al. 1995, Wang, Okamoto et al. 1997, Wang, Sugita et al. 2000, 
Dresbach, Qualmann et al. 2001, Wang and Sudhof 2003). The proteins 
interact with each other and other synaptic components such as Piccolo and 
Bassoon, that are large homologous proteins forming part of the cytomatrix 
(Cases-Langhoff, Voss et al. 1996, tom Dieck, Sanmarti-Vila et al. 1998); 




and receptor protein tyrosine phosphatases (Serra-Pages, Medley et al. 1998, 
Wang, Sugita et al. 2000, Ohtsuka, Takao-Rikitsu et al. 2002, Wang, Liu et al. 
2002, Ko, Na et al. 2003). 
With the help of numerous proteins, the SV is first tethered in close 
vicinity to the active zone, docked in direct contact with the plasma membrane 
and “waiting” for fusion (Dresbach, Qualmann et al. 2001, Jahn and Fasshauer 
2012). After docking, a priming reaction leaves the SV in a metastable state, 
which allows it to be ready to release its cargo upon Ca2+ influx. Membrane 
fusion requires energy which is provided by the SNARE proteins (Soluble N-
ethylmaleimide sensitive factor Attachment protein Receptor) (Weber, 
Zemelman et al. 1998). Prior to the Ca2+ influx a trans-SNARE complex is 
formed by the SV localized SNARE protein synaptobrevin-2/VAMP2, the 
plasma membrane associated syntaxin-1 and SNAP-25 (Sudhof and Rizo 
2011). The binding of Ca2+ to the Ca2+-sensing protein synaptotagmin (Syt) 
leads to conformational changes in Syt and within 100 µs after the arrival of an 
AP the fusion of SVs occur (Rizo and Rosenmund 2008). 
Most vesicles that are docked and primed belong to the readily-
releasable pool (RRP) (Denker and Rizzoli 2010). These SVs are immediately 
available upon stimulation and can be rapidly depleted with high frequency 
stimulation. Two other SV pools can be distinguished: the recycling pool and 
the reserve pool. The SVs from the reserve pool are rarely utilized during 
physiological activity while the recycling pool maintains release in response to 
moderate stimulation and is refilled by newly recycled vesicles (Rizzoli and 
Betz 2005). 
Following exocytosis SVs need to be regenerated. Membrane 
originating from SVs are retrieved and parts of the protein release machinery 
is recycled and sorted. Finally, the newly formed SVs are filled with NT (Rizzoli 
2014). The vesicular ATPase, located in the vesicle membrane, hydrolyzes 
adenosine triphosphate (ATP) in order to pump protons into SVs, thus creating 
both a proton gradient and an electrical potential across the vesicular 
membrane. This electrochemical gradient is further used by NT transporters, 




to pump NTs into the vesicles (Hammond 2001, Chanaday, Cousin et al. 
2019). 
Several mechanisms have been proposed for the recovery of SVs at 
the synapse: fusion pore closure “kiss and run”, clathrin mediated endocytosis 
directly from the plasma membrane (CME), activity-dependent bulk 
endocytosis (ADBE) and ultrafast endocytosis. The “kiss and run” model 
proposes that SVs are quickly recycled by a direct reversal of the exocytotic 
process without an intermixing between the SV and presynaptic plasma 
membrane (Valtorta, Meldolesi et al. 2001, Alabi and Tsien 2013).  
During CME, clathrin-coated pits invaginate from the membrane surface 
and with the help of other proteins pinch off from the membrane. The clathrin 
coat subsequently falls off and these vesicles can be directly filled with NT 
(Conner and Schmid 2003, Doherty and McMahon 2009, Saheki and De 
Camilli 2012). 
 An alternative proposed mechanism of endocytosis during more 
intense neuronal activity is the ADBE (Clayton and Cousin 2009, Morton, 
Marland et al. 2015). In ADBE large areas of the plasma membrane 
invaginates to form bulk endosomes from which SVs are generated to 
replenish the recycling pool (Wenzel, Morton et al. 2012, Morton, Marland et 
al. 2015). 
Recently a new mechanism, ultrafast endocytosis, has been proposed 
for the recycling of SVs. In a clathrin-independent manner, a single large 
endocytic vesicle (50-100 ms) is retrieved after vesicle fusion. Dynamin is 
required for the step of invagination. Clathrin is required later for the formation 
of SVs from the endosome (Watanabe, Rost et al. 2013, Watanabe, Trimbuch 






Figure 1: The synaptic vesicle cycle.  
Vesicles are filled with neurotransmitters. The SV docks at the plasma membrane in the 
active zone and becomes primed. Upon calcium influx fusion occurs and neurotransmitters 
are released. After this the membrane is retrieved by endocytosis and the SV undergoes a 





Studying NT release 
 Work by Katz, Eccles and others using electrophysiological 
measurements showed the central importance of synapses for brain function 
and characterized the basic mechanisms involved in synaptic transmission. 
Over the last decades, many molecular functions of synapses have been 
understood and elucidated. Moreover, technical advances that went beyond 
the classical approaches have provided more details and insights. These 
include capacity measurements of exocytosis directly at the presynapse and 
the controlled release of Ca2+ by uncaging experiments (Neher and Marty 
1982, Delaney and Zucker 1990). Other methods are based on imaging 
analysis such as the use of FM1-43 or Synapto-pHluorin. They provide the 
possibility to visualize the release of SVs as well as their internalization and 
reacidification during endocytosis (Rizzoli and Betz 2005). 
 Many studies aimed to elucidate motives for circuits such as 
feedforward, feedback, recurrent and lateral inhibition and excitation (Douglas 
and Martin 2007, Yuste 2015). One of the simplest circuit motives imaginable, 
namely the synaptic connection of a neuron with itself, was only recognized 
relatively late. The term "autapse" entered the encyclopedia of neuroscience 
in 1972 (Van Der Loos and Glaser 1972). 
 
The Autaptic culture system 
Autaptic cultures, in which single neurons grow in isolation on astrocytic 
microislands and form synapses exclusively with themselves (Bekkers and 
Stevens 1991), provide an experimental system with access to detailed 
characteristics underlying synaptic transmission. This system allows for the 
quantitative assessment of input and output properties of individual neurons, 
both in morphological and in functional experiments (Sampathkumar, Wu et al. 
2016). In addition, parameters such as vesicle fusogenicity, vesicular release 
probability (PVR), short-term plasticity and SV pool sizes can be assessed 
(Figure 2) (Basu, Betz et al. 2007, Trimbuch, Xu et al. 2014). The autaptic 




release mechanisms, including docking/priming and the functionality of the 
fusion machinery (Rhee, Betz et al. 2002, Varoqueaux, Sigler et al. 2002, 
Basu, Shen et al. 2005, Rhee, Li et al. 2005, Li, Shin et al. 2006, Arancillo, Min 
et al. 2013, Schotten, Meijer et al. 2015, Camacho, Basu et al. 2017, Lipstein, 
Verhoeven-Duif et al. 2017), as well as developmental phenotypes 
(Sampathkumar, Wu et al. 2016). Moreover, it has been a powerful tool to 
distinguish between cell-autonomous and non-cell-autonomous regulatory 
processes (Chang, Trimbuch et al. 2014, Sampathkumar, Wu et al. 2016) and 
to describe the cellular phenotypes associated with neurological disorders, 
e.g. Rett syndrome (Chao, Zoghbi et al. 2007, Chao, Chen et al. 2010, 
Sampathkumar, Wu et al. 2016), and neurodegenerative diseases such as 





Figure 2: The autaptic cell culture system 
A) A schematic of the autaptic culture system with a neuron sitting on a feeder island. The 
dendrites are confined to the borders of the island and are making repeated autaptic 
connections to the axon. Credit: Christian Rosenmund. B) A schematic of our fast flow 
system. The position of the opening of each pipe is centered to the soma (aCSF: artificial 
cerebrospinal fluid; NBQX: 2,3-Dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-
sulfonamide; KYN: kynurenic acid). With the help of a computer controlled stepper and valve 





Human neurons as model system 
In order to understand the neuronal function of humans, it is crucial to 
gain knowledge of how human synapses function. For this purpose, new 
approaches are needed to define unique properties of human synapses. 
Progress in the analysis of the human genome has led to the discovery 
of many new monogenetic disorders of the CNS. While this has helped in the 
diagnosis of rare diseases, understanding the underlying pathophysiology is a 
greater challenge. Research on model organisms including the worm, fly, fish 
and rodent has been used with good success to date to summarize both 
organismic and cellular aspects of the genetic defects (Hofker, Fu et al. 2014). 
However, it is still unclear how well these model organisms reflect the situation 
in human patients. Similarly, the mechanisms of NT release have been studied 
for decades in different invertebrate and vertebrate model systems (Fatt and 
Katz 1951, Furshpan and Potter 1959, Jan, Jan et al. 1977, Borst, Helmchen 
et al. 1995, Moyer and Brown 1998, Zhen and Jin 1999, Bischofberger, Engel 
et al. 2006). The rodent model system has proven especially valuable for 
modeling monogenic human diseases and understanding their underlying 
causes (Comery, Harris et al. 1997, Jiang, Armstrong et al. 1998, Asaka, 
Jugloff et al. 2006, Hung, Futai et al. 2008, Chao, Chen et al. 2010, Michalon, 
Sidorov et al. 2012, Schmeisser, Ey et al. 2012, Kouser, Speed et al. 2013, 
Fromer, Pocklington et al. 2014, Purcell, Moran et al. 2014, Duffney, Zhong et 
al. 2015). 
Recent technological advances now provide access to human neurons 
through the establishment of induced pluripotent stem cells (iPSCs) and 
neuronal differentiation protocols (Chambers, Fasano et al. 2009, Shi, Kirwan 
et al. 2012, Zhang, Pak et al. 2013, D'Aiuto, Zhi et al. 2014, Gunhanlar, Shpak 
et al. 2018). Alternatively, direct conversion of fibroblasts into neurons can be 
performed (Vierbuchen, Ostermeier et al. 2010, Colasante, Lignani et al. 
2015). 
Two potential advantages of cultured human neurons are that first they 




for the study of complex genetic diseases by employing iPSCs generated 
directly from the affected patient. Importantly, the usage of iPSCs makes the 
replacement of transgenic animal lines possible. To date, transgenic animals 
are still the basis for research in the field of synaptopathies (Hook, Brennand 
et al. 2014, Mertens, Wang et al. 2015, Pak, Danko et al. 2015, Yi, Danko et 
al. 2016, Young-Pearse and Morrow 2016, Forrest, Zhang et al. 2017).  
Induced Neurons (iNs) possess great potential for studying the basic 
mechanisms of NT release in a controlled genetic background (Pak, Danko et 
al. 2015, Patzke, Han et al. 2015). Recent studies have investigated evoked 
NT release in human iNs grown in mass culture (Zhang, Pak et al. 2013, Pak, 
Danko et al. 2015, Patzke, Han et al. 2015, Patzke, Acuna et al. 2016, 
Gunhanlar, Shpak et al. 2018). However, the depth of analysis of synaptic 
properties and parameters has been limited due to the complex network 
formed in this conventional culture system.  
 So far, the poor survival rate of solitary human iNs, which is 
necessary to obtain autaptic cultures, and their long differentiation time in 
comparison to rodent primary neurons has hampered the accessibility of these 
cultures to experimental assessments. Moreover, the research community is 






Aims of this study 
Synaptic transmission has been studied over the last decades mainly in 
different model organisms, including invertebrates and vertebrates. Autaptic 
cultures for the investigation of synaptic transmission were performed mainly 
on neurons of mice and rats. One reason for this was that the accessibility of 
human neurons was restricted.  
Our primary aim was to transfer the increasing number of studies on 
human iNs performed in conventional mass cultures to the autaptic model for 
the first time. For this purpose, we developed a novel two phase culture system 
for human autaptic cultures.  
The second aim was to characterize basic morphology parameters 
including axon and dendrite length as well as synapse formation by 
immunocytochemistry. In the next step we wanted to characterize the basic 
physiological parameters to access the synaptic input and output function, and 
determine synaptic efficacy. Therefore, we performed electrophysiological 
recordings including the assessment of modulation of synaptic responses by 
endogenous and exogenous modifiers of synaptic transmission. 
 The third aim was to show an application-based validation of the 
autaptic human neurons from human iPSC. This would allow us to 
demonstrate the reliability of our cell culture system of human neurons as a 
replacement of the animal autaptic model system to study synaptic 
transmission. As a proof of principle, we first used a small hairpin ribonucleic 
acid (shRNA) based knocked down of UNC 13-A in an acute manner. As a 
second approach we generated a human stem cell line deficient for 
Synaptotagmin 1. We therefore can test the sensitivity of human autaptic 
cultures for the investigation of synaptic transmission in comparison to the 
known effects of Synaptotagmin 1 deficiency in the rodent models.  
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Materials and Methods 
Animals 
C57BL6/N mice were used in this work to obtain astrocyte enriched 
primary cultures. All procedures to maintain and use mice were approved by 
the Animal Welfare Committee of the Charité Medical University and the Berlin 
State Government (license no. T0220/09). 
 
Cell culture 
Maintenance of iPSC 
IPSCs were obtained from three independent lines provided by the 
Berlin Institute of Health Core Facility Stem Cells (Berlin, Germany): The iPSC 
line BIHi001-A (https://hpscreg.eu/cell-line/BIHi001-A) was derived from 
human foreskin fibroblasts using Sendai virus vectors (CytoTune-iPSC 
reprogramming kit, ThermoFisher Scientific, Waltham, MA, USA). The iPSC 
line BIHi004-A (https://hpscreg.eu/cell-line/BIHi004-A) was derived from 
human fibroblasts using episomal vectors (Epi5 Episomal iPSC 
Reprogramming Kit, ThermoFisher Scientific). The iPSC line BIHi005-A 
(https://hpscreg.eu/cell-line/BIHi005-A) was derived from fibroblast of dermis 
in the OLS using Sendai virus vectors (Miltenyi mRNA, Miltenyi Biotec, 
Germany). IPSCs were maintained as feeder-free cells in StemFlex medium 
(ThermoFisher Scientific) in a standard incubator (37 °C, 5 % CO2). 
 
Preparation of microdot patterned glass coverslips 
Glass coverslips (30 mm diameter, (Glaswarenfabrik Karl Hecht, 
Germany)) were cleaned with 1 M HCl (Carl Roth, Germany) on a shaker 
overnight, rinsed three times with ddH2O and finally stored in 95 % ethanol 
(Carl Roth, Germany). To remove the alcohol coverslips were briefly flamed 
before placing them into 6-well-plates (Corning, Inc, USA). In a next step, glass 
coverslips were then coated with liquefied 0.15 % agarose type IIa (Sigma-
Aldrich, Germany). The coating forms a thin layer on which cells are reluctant 
Material and Methods 
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to attach. Using a custom-built stamping machine uniformly sized microislands 
(~200 µm diameter, 500 µm space between spots) of a permissive growth 
solution (collagen/poly-D-lysine) (Gibco Life Technologies, Germany and 
Sigma Aldrich, Germany) were applied to the agarose coated glasses. Plates 
with micropatterned glasses were sterilized using ultraviolet light and stored at 
room temperature (RT) until further use.  
 
Preparation of astrocytes 
Astrocytes were obtained from newborn C57/BL6-N mice. Briefly, 
animals were sacrificed and brains were removed. Brains were quickly 
transferred into 4 °C cooled Hank‘s Balanced Salt Solution (HBSS, Gibco Life 
technologies, Germany). Under a binocular microscope the cortices were 
dissected and the meninges removed. Cortices were digested for 20 minutes 
at 37 °C in a shaker at 800 revolutions per minute with 800 µl of 0.05 % trypsin-
EDTA (ethylenediaminetetraacetic acid). Digested cortices were placed in 
DMEM (Dulbecco!s Modified Eagle!s - Medium) full medium and triturated to 
obtain a suspension of dissociated cells. 400 µl cell suspension were placed 
into a flask (surface area 75 cm2) (Corning, Inc, USA) containing 13 ml pre-
warmed DMEM full medium. Flasks were stored in an incubator (37 °C, 5 % 
CO2) to allow the astrocytes to grow for 1 to 2 weeks. After reaching 80 % 
confluency, astrocyte flasks were vortexed for approximately 1 minute. Cells 
were washed with phosphate-buffered saline (PBS) and detached from the 
surface by adding 5 ml of 0.05 % trypsin-EDTA. 7 ml DMEM full medium was 
added to stop digestion and cells were dissociated and transferred into tubes 
for centrifugation for 5 min at RT and 300 relative centrifugal force (rcf). After 
centrifugation the cells were counted and ready for plating. Astrocytes were 
plated at a density of 5 x 103 cells per cm2 onto the microdot-coated coverslips 
one week before iNs were added. For the addition of astrocytes during the 
induction process the same protocol to detach the cells was used. After the 
centrifugation the cell pellet was resuspended in Neurobasal A (NBA) + media 
and the cell suspension was added to the human iNs. 




Lentiviruses were produced by cotransfection of HEK293T cells with 
3.9 µg of pRSV-REV (Addgene Plasmid #12253), 8.1 µg pMDLg/pRRE 
(Addgene Plasmid #12251) packaging plasmids, 6 µg of envelope plasmid 
VSVg (Addgene Plasmid #12259)) and 12 µg complementary DNA (cDNA) 
transfer plasmids containing the construct of interest (e.g. Tet-O-FUW or 
FUGW) in a T75 flask using calcium phosphate. 24 h before transfection  
6.8 x 106 HEK (Human embryonic kidney cells) cells were seeded in the T75 
bottle. One hour prior to transfection, medium was changed for new DMEM 
with 10 % fetal calf serum (FCS). The required plasmids (see above) were 
mixed with 111.6 µl 2M CaCl and 768 µl H2O. This mixture was then added 
slowly and dropwise to 900 µl 2 x HBS (HEPES (4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid) -Buffered Saline) and shaken horizontally for 
10 sec in a 14 ml round bottom tube. After 20 minutes incubation at RT without 
shaking, the transfection mix was added to the HEK cells. 5 h later the media 
was replaced with DMEM containing 10 % FCS and cells were incubated at 
37 °C in the incubator. 
Supernatants containing lentivirus particles were harvested 48 h after 
transfection and purified using Amicon Ultra-15 Centrifugal Filter units Ultracel-
100K (Merck Millipore, MA, USA). Thus the 12 ml of the supernatant were 
concentrated to 200 µl. The virus was then stored in 20 µl aliquots at -80 °C 
until use. Only virus batches with > 90 % infection efficiency, as assessed by 
green fluorescent reporter expression (FUW-eGFP) or by 90 % survival cells 
by brightfield puromycin resistance (FUW-TetO-Ngn2-T2A-Puro), were used 
for experiments. cDNA constructs for rtTA (FUW-rtTA), Ngn2 (FUW-TetO-
Ngn2-T2A-Puro) and eGFP (FUW-eGFP) were kindly provided by Thomas C. 
Südhof, (Stanford University School of Medicine, USA). For Unc13A 
knockdown (KD) a synthetic shRNA oligonucleotide (sequence:  
5’ ggacaccatcaagcaatat ttcaagaga atattgcttgatggtgtcc ttttttccaa 3’) was 
inserted into a FUGW shuttle vector (Lois, Hong et al. 2002) containing a U6 
promoter and a synapsin promoter driven NLS-RFP reporter gene. 
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Generation of iN Cells from human iPSCs 
Excitatory human iNs were produced essentially as described 
previously (Zhang, Pak et al. 2013). On day -1, seeded iPSCs were 
dissociated with Accutase cell dissociation reagent (ThermoFisher Scientific) 
and re-seeded on 6-well plates coated with Matrigel (Corning) (300 K per well) 
in StemFlex Medium containing 2 µM Thiazovivin (Tocris, Bristol, UK) and 
lentiviral particles for transduction of Neurogenin-2 (NGN2), rtTA and eGFP. 
On day 0 the culture medium was changed to DMEM/F12 (DMEM+) 
(ThermoFisher Scientific), supplement with N-2 (ThermoFisher Scientific), 
non-essential amino acids (ThermoFisher Scientific), human Brain-derived 
neurotrophic factor (BDNF) (10 mg/l, PeproTech, Hamburg, Germany), human 
NT-3 (10 mg/l, PeproTech), mouse laminin (0.2 mg/l, ThermoFisher Scientific) 
as well as doxycycline (2 µg/ml, Sigma Aldrich) to induce TetO-dependent 
gene expression. Doxycycline was included in all media until the end of the 
experiments. On day 1, the medium was changed as described above and 
additionally 0.5 mg/l puromycin was included to select for iNs. This was 
achieved as the NGN2 plasmid contains a puromycin resistance cassette. On 
day 3, the medium was replaced with NBA+ medium (ThermoFisher 
Scientific), which included B-27 supplement (ThermoFisher Scientific), 
GlutaMAX (ThermoFisher Scientific) human BDNF (10 mg/l), human NT-3  
(10 mg/l), mouse laminin (0. 2 mg/l), cytosine β-D-Arabinofuranoside (Ara-C) 
(2 mg/ml, Sigma Aldrich) and doxycycline (2 µg/ml). Additionally, mouse 
astrocytes were added at the density of 3 x 105 cells/cm2 at the same time 
period. From day 7 on, half of the medium in each well was replaced every 5 
days by NBA+ medium containing B-27 supplement, GlutaMAX, doxycycline 
(2 µg/ml) and 2.5 % fetal bovine serum (Pan Biotech, Aidenbach, Germany). 
After 50-70 days cells were washed twice with 0.5 mM EDTA/PBS 
(ThermoFisher Scientific) and dissociated with Accutase Cell Dissociation 
Reagent (twice for 7 min at 37 °C). Only the GFP-positive cells were counted 
in a hemocytometer under a fluorescence microscope and seeded at a density 
of 4 K per well on astrocyte feeder micro-islands glass to obtain induced 
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human neuronal autaptic cultures. Cells on microislands were seeded in media 
containing NBA for human iN mass cultures supplemented with human BDNF 
(10 mg/l), human NT-3 (10 mg/l) and mouse laminin (0. 2 mg/l). These cultures 
were maintained in a humidified incubator (37 °C and 5 % CO2) for 13-21 days. 
 
Media and cell culture solutions 
DMEM full 
Component Volume (ml) 
Fetal calf serum 50 
Penicillin / Streptomycin 
(10.000 U/ml; 10.000 µg/ml) 
5 




PBS 500 ml 




StemFlex medium 450 ml 
StemFlex supplement 50 ml 
 
2x HBS pH 6.95 
Component Amount 
NaCl 16 g 
HEPES 10 g 
Glucose 2 g 
KCl 0.74 g 
Na2HPO4  0.212 g 
H2O Add to 1000 ml 
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DMEM+ medium  
Component (unit) Volume (µl) 
N2  500 
NEAA  500 
BDNF (10 µg/ml) 50 
Laminin (1000 µg/ml) 10 
NT3 (10 µg/ml) 50 
Doxycycline (1000 µg/ml) 100 




Component (unit) Volume (µl) 
B27 1000 
GlutaMAX 500 
BDNF (10 µg/ml) 50 
Laminin (1000 µg/ml) 10 
NT3 (10 µg/ml) 50 
Ara-C (50000 mg/ml) 2 
Doxycycline (1000 µg/ml) 100 
NBA  48,5 ml 
 
NBA for human iN mass culture 
Component (unit) Volume (ml) 
B27 10 
Glutamax 5 
FBS  12,5 
Penicillin / Streptomycin  
(10.000 U/ml; 10.000 µg/ml) 5 
Doxycyclin (1000 µg/ml) 1 
NBA  500 
  




Autaptic human induced neuronal cultures were fixed between day 80 
and 121 in 4 % paraformaldehyde (PFA, Sigma Aldrich) / 4 % sucrose (Sigma 
Aldrich) in PBS (Merck Millipore) for 10 min at RT and washed three times with 
PBS. Cells were permeabilized for 15 min in PBS with 0.1 % Tween-20  
(Carl-Roth GmbH + Co. KG, Karlsruhe, Germany) (PBS-T), incubated in 
quenching solution (100 mM glycine in PBS) for 30 min and blocked in 5 % 
normal donkey serum (Jackson ImmunoResearch Inc., West Grove, PA, USA) 
(in PBS) for 1 hour at RT. Autaptic human iNs were incubated with primary 
antibodies in blocking solution over night at 4 °C. The following primary 
antibodies were used: chicken anti-microtubule-associated protein 2 (MAP2) 
(1:2000; Merck Millipore, AB5543), mouse anti-pan-axonal neurofilaments 
(SMI-312; 1:1000; Covance inc., Princeton, NJ, USA); mouse anti-
synaptotagmin-1 (1:200; Synaptic Systems, Göttingen, Germany, 105 011). 
After primary antibody incubation, human iNs were washed three times with 
PBS-T, and secondary Alexa-Fluor 405 or 647 (1:500; Jackson 
ImmunoResearch Inc.) antibodies were added for 1 h at RT in PBS-T. Cells 
were washed twice in PBS-T and once in PBS before they were mounted on 
glass slides with Mowiol (ThermoFisher Scientific). 
 
Morphological analysis 
For morphological analysis of autaptic human induced neuronal 
cultures, stacks of 16-bit fluorescence images were acquired on an Olympus 
IX81 inverted fluorescence microscope equipped with a 10 X or 20 X objective 
(neurite length analysis) or a 60 X water immersion objective (synaptic density 
analysis). Images were acquired with a CCD camera (Princeton MicroMax; 
Roper Scientific, Trenton, NJ) using MetaMorph software (Molecular Devices, 
Sunnydale, CA, USA). All images were analyzed using ImageJ software 
(National Institutes of Health, Bethesda, MD, USA). For each image stack 
maximum intensity projection were generated. Uniform background 
subtraction and optimal threshold adjustment was performed on all images. 
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Quantification of MAP2-positive or neurofilament (SMI312)-positive processes 
with the NeuronJ plugin was used to determine total dendritic and axonal 
lengths, respectively. The density of synaptophysin-positive punctae 
overlapping with MAP2-positive dendrites was determined using a custom-
written ImageJ plugin. Two independent cultures were imaged and analyzed 
per group for every experiment. 
 
Electrophysiology 
Whole-cell patch-clamp recordings were performed in single human iNs 
between day 63 and 91 post neuronal induction at RT using a Multiclamp 700B 
amplifier (Molecular Devices). The series resistance was compensated by  
70 % and only cells with series resistances of < 12  MΩ were analyzed. Data 
were acquired at 10 kHz using pClamp 10 software (Molecular Devices) and 
filtered using a low-pass Bessel filter at 3 kHz. Data were analyzed offline using 
AxoGraph X (AxoGraph Scientific). The patch pipette solution contained 
136 mM KCl, 17.8 mM HEPES, 1 mM EGTA, 0.6 mM MgCl2, 4 mM ATP-Mg, 
0.3 mM GTP-Na, 12 mM phosphocreatine, and 50 units/mL phosphocreatine 
kinase (300 mOsm, pH 7.4, all Carl-Roth). The recording chamber was 
constantly perfused with extracellular solution containing 140 mM NaCl, 2.4 
mM KCl, 10 mM HEPES, 2 mM CaCl2, 4 mM MgCl2, and 10 mM glucose (pH 
adjusted to 7.3 with NaOH, 300 mOsm, all Carl-Roth). For experiments 
examining postsynaptic receptors (Figure 5 D; Figure 9) we used a Mg2+-free 
extracellular solution containing 10 µM glycine. Solutions were applied using 
a fast-flow perfusion system. 
 For whole-cell voltage clamp recordings, neurons were maintained at  
-70 mV holding potential. Cells were subjected to 500 ms depolarizations in  
10 mV steps from −90 mV to +50 mV to analyze Na+/Ca2+ and K+ currents. 
 AP firing patterns and passive membrane properties were recorded in 
whole-cell current-clamp configuration. Bridge balance was automatically 
compensated. 300 ms current steps from -40 pA to 120 pA were injected. The 
resting membrane potentials were analyzed from baseline and the input 
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resistances were calculated by Ohms law using a current step of -50 pA for 
600 ms. 
 Membranes standing glutamatergic and GABAergic ionotropic receptor 
function were tested by pulsed application (1 s) of 20 µM kainic acid, 100 µM 
N-Methyl-D-aspartic acid (NMDA) and 5 µM γ-Aminobutyric acid (GABA) (all 
Tocris). Peak amplitudes from six consecutive sweeps were averaged. The 
values were normalized to the cell capacitance. 
 Excitatory postsynaptic currents (EPSCs) were evoked by a 2 ms 
somatic depolarization from −70 to 0  mV producing an unclamped axonal AP. 
To determine the size of the RRP, 500  mM sucrose (Sigma Aldrich) solution 
was applied for 5 s and the resulting transient inward current was integrated 
(Rosenmund and Stevens 1996). Miniature excitatory postsynaptic currents 
(mEPSC) were detected using a sliding template function in AxoGraph X 
(Clements and Bekkers 1997) and false positive events were corrected by 
using the selective competitive α-amino-3-hydroxy-5-methyl-4-
isoxazolepropionic acid (AMPA) receptor antagonist 2,3-Dioxo-6-nitro-1,2,3,4-
tetrahydrobenzo[f]quinoxaline-7-sulfonamide (NBQX; 3 µM (Tocris)). The 
number of vesicles (nRRP) in the RRP was calculated by dividing the charge of 













The PVR was calculated as the ratio of the average EPSC charge 
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The spontaneous release rate was determined by dividing the mEPSC 
frequency by the number of vesicles in the RRP for each cell. The paired-pulse 
ratio (PPR) was calculated by applying two stimuli with an inter-stimulus 
interval (ISI) of 25 ms and dividing the amplitude of the second EPSC by the 
first EPSC. 
For pharmacological studies with 30 µM L-(+)-2-Amino-4-
phosphonobutyric acid (L-AP4) (Tocris), 20 µM R-Baclofen (Tocris),  
10 µM D-(-)-2-Amino-5-phosphonopentanoic acid (D-AP5) (Tocris),  
3 µM NBQX (Tocris) and 1 µM (2S,2'R,3'R)-2-(2',3'-Dicarboxycyclopropyl) 
glycine (Tocris) baseline EPSC amplitudes were monitored at 0.2  Hz for 30  s 
without drug application, followed by 30 s in the presence of the drug and 
another 30  s in the absence of the drug. The degree of EPSC depression or 
potentiation was determined by dividing the mean EPSC amplitude in the 
presence of the drug by the overall mean EPSC amplitude before and after 
drug application in standard extracellular solution of each cell. The degree of 
EPSC potentiation induced by 1 µM phorbol-12,13-dibutyrate (PDBu) (Tocris) 
was determined by monitoring EPSC amplitudes at 0.2 Hz for 15 s in standard 
extracellular solution followed by 30 s under PDBu application. The degree of 
potentiation was calculated by normalizing the EPSC amplitudes recorded 




For quantification of Unc13A and protein levels, human iN were lysed 
14 days post transduction at 4 °C with lysis buffer (50 mM Tris, pH 8.0, 150 
mM NaCl, 0.2 % NP-40, protease inhibitor cocktail complete mini (Roche 
Diagnostics)). Equal amounts of total protein from the lysates of human iNs 
transduced with Unc13A-KD or scrambled control virus were separated on 
SDS polyacrylamide gel and transferred to a nitrocellulose membrane. 
Membranes were blocked for 1 h with 5 % skim milk in PBS-T and incubated 
at 4 °C over night with primary antibodies in blocking solution: anti-Munc 13-1 
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(126103 Synaptic Systems) and anti- β-Tubulin III (T8660 Sigma-Aldrich). 
Following three 10 min washes with PBS-T the membranes were incubated 
with the horseradish peroxidase-conjugated secondary antibodies (Jackson 
ImmunoResearch) in PSB-T for 1h at RT. Detection was performed by using 
ECL Plus Western Blotting Detection Reagents (GE Healthcare Biosciences) 
in a Fusion FX7 detection system (Vilber Lourmat). Data were analyzed offline 
using ImageJ. 
To confirm that no Syt1 protein is detectable in the constitutive KO of 
Syt1, the same protocol as described above was used. The following primary 
antibodies were used: anti-Syt1 (105011 Synaptic Systems) and anti- β-
Tubulin III (T8660 Sigma-Aldrich). 
 
Genetic modification by CRISPR/Cas9 
Ribonucleoprotein complex formation and Nucleofection 
For the generation of a constitutive iPSC knock out (KO) line for the 
presynaptic protein Syt1, we used an approach where we delivered a 
ribonucleoprotein complex (RNP), composed of a short-guided RNA (sgRNA) 
and the Cas9 Nuclease. 
For designing the side specific sgRNAs we used different tools, from 
Synthego, IDT, and Crispor. In total, we generated 8 different sgRNAs with 
each platform and had them cross-validated for their on target specificity and 
off target sites. We decided to attribute a higher value to off target effects than 
to on target activity. After completion of the analysis, we obtained the four most 
highly valued sgRNAs (see Figure 12). 
To obtain the sgRNA we used the cr:tracrRNA method (trans-activating 
CRISPR RNA (tracrRNA), CRISPR RNAs (crRNA)). We obtained both 
components (Alt-R CRISPR-Cas9 crRNA and Alt-R CRISPR-Cas9 tracrRNA) 
synthesized from IDT. To build the cr:tracrRNA duplex 10 µl of 200 µM crRNA 
and 10 µl of 200 µM tracrRNA were mixed and incubated for 2 minutes at  
94 °C without shaking. The complex was then slowly cooled to RT and stored 
at -20 °C until use. 
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One day prior nucleofection two times 500 K cells per nucleofection 
were seeded. For the formation of the sgRNA/Cas9 complex, 2 µl sgRNA were 
mixed with 2 µl Cas9 protein (HiFi Cas9 Nuclease V3 from IDT) and incubated 
for about 20 min at RT. Afterwards, the nucleofection mix was prepared 
consisting of 82 µl P3 buffer, 18 µl of Supplement 1 (Amaxa Primary Cell Kit 
P3) and 4 µl of sgRNA/Cas9 complex with 1 µl IDT electroporation enhancer. 
The iPSCs were then detached using Accutase and centrifuged for 5 min at 
300 x g. The supernatant was completely aspirated and iPSCs were 
resuspended in the nucleofection mix. The sgRNA/Cas9 complex was 
delivered by nucleofection into the iPSC using an Amaxa 4D Nucleofector 
(Lonza). The CM-150 program on the Amaxa 4D Nucleofector was used for 
electroporation. Immediately after nucleofection the transfected iPSCs were 
seeded into a new 6 well containing StemFlex medium with 2 µM Thiazovivin. 
Four hours later the complete StemFlex medium in each well was replaced. 
 
CRISPR editing results analysis 
The bioinformatics tool ICE (Inference of CRISPR Edits) from Synthego 
was used to determine the efficiency of the sgRNAs. With the help of this tool, 
it is possible to obtain results by normal sanger sequencing that come to the 
quality of next generation sequencing. It only requires a purified PCR product 
over the sgRNA cleavage site, whose DNA sequence is being compared with 
an unedited control sequence. DNA was isolated 48 h after sgRNA/Cas9 
complex nucleofection of the cells. For DNA isolation the NucleoSpin Tissue 
KIT (Macherey Nagel) was used according to the manufacturer's instructions, 
with the modification that only 50 µl buffer BE for eluting the DNA from the 
column was used. The PCR was performed on the on target side using the 
primers listed below and the PCR fragment was purified with the QIAquick Gel 
Extraction Kit (Qiagen). The purified DNA was sent at a concentration of  
10 ng/µl for Sanger sequencing using the ready2run sequencing service from 
LGC Biosearch with the reverse primer of the PCR product (listed below).  
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The sequencing results were analyzed online in comparison to an unedited 
control sequence on the Synthego website. 
 
On target PCR for ICE analysis 
For the ICE analysis a fragment with a size of 435 bp was produced. 
Primers 
Primer name Primer Sequence 
Forward 500 bp GCCCATGAGTTAAAAGGTTTTCCA  
Reverse 500 bp ACCCTGCCAAATGCTTCCAT 
 
PCR Protocol 
Component Concentration Amount 
Forward 500 bp 10 pmol/µl 2.5 µl 
Reverse 500 bp 10 pmol/µl 2.5 µl 
Phusion GC Buffer 5x 10.0 µl 
Phusion DNA 
Polymerase 
2U/µl 0.5 µl 
DMSO  2.5 µl 
dNTPs 2.5 mM each 2.0 µl 
H2O  29.0 µl 
Template DNA  1.0 µl 
 
Cycling Parameters 
Step Temperature Time 
1 98 °C 30 sec 
2 98 °C 7 sec 
3 65 °C 15 sec 
4 72 °C 10 sec 
Cycle back to Step 2 35 times 
5 72 °C 10 min 
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Generation of single clones 
To generate individual clones of the selected KO Syt-1 and thus a new 
clonal cell line, the cells were nucleoporated with sgRNA #1 as described 
above. This sgRNA was chosen as it proved to be the one with the highest 
efficiency in the previously conducted preliminary tests. After nucleoporation, 
the cells were placed in StemFlex medium containing CloneR (STEMCELL 
Technologies). 24 h later, a limited dilution was performed with one cell per 
200 µl of medium. A total of 192 wells were plated in 48 well plates with 200 µl 
per each well. The medium was changed every 24 h. CloneR supplement was 
included in the medium for the first 72 h. Afterwards StemFlex medium 
according to the manufactures protocol was used. During the next three to four 
weeks, the cells were continuously expanded, until two confluent wells of each 
original colony were obtained in a 12-well plate. One well was cryopreserved 
in Bambanker (NIPPON Genetics) and stored at -80 °C until further use. The 
other well was used to isolate DNA as described above and used for the 
confirmation of the correct genetic modification. 
 
Control for OFF-target effects, clonality and karyotyping 
Amplicon next generation sequencing was used (Amplicon-EZ, 
Genewiz) to check individual iPSC clones for their clonality. For this a purified 
PCR fragment (See above for the procedure. Primers for the PCR fragment 
are listed below) of 500 ng (20 ng/µl) was used. The analysis of the sequencing 
data generated from the Illumina platform was performed directly by the 
sequencing company (Genewiz).  
After clonality was confirmed the clones were analyzed for their 
karyograms (in collaboration with the BIH core facility Stemcells and the 
Human Genetics Practice of the Charité Berlin). Freshly thawed iPSC clones 
were passaged 5 times and sent for diagnostic analysis at the Institute of 
Medical and Human Genetics of the Charité Berlin. 
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Off-target effects off sgRNA were assessed by normal sanger 
sequencing and Cas-OFFinder (CRISPR RGEN Tools, 
http://www.rgenome.net/cas-offinder) with a mismatch number of 2 or less.  
 
Amplicon NGS and off target PCR  
For the NGS analysis a fragment of 199 bp was produced. 
Primers 
Primer name Primer Sequence 
Forward NGS GCCCATGAGTTAAAAGGTTTTCCA  
Reverse NGS TTCCCTCCTTTTTCCTTTCCC 
 
PCR Protocol 
Component Concentration Amount 
Forward 500 bp 10 pmol/µl 2.5 µl 
Reverse 500 bp 10 pmol/µl 2.5 µl 
Phusion GC Buffer 5x 10.0 µl 
Phusion DNA 
Polymerase 
2U/µl 0.5 µl 
DMSO  2.5 µl 
dNTPs 2.5 mM each 2.0 µl 
H2O  29.0 µl 
Template DNA  1.0 µl 
 
Cycling Parameters 
Step Temperature Time 
1 98 °C 30 sec 
2 98 °C 7 sec 
3 62 °C 15 sec 
4 72 °C 10 sec 
Cycle back to Step 2 35 times 
5 72 °C 10 min 
6 12 °C ∞ 
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Off target PCR conditions 
The following primer pairs were used to detect off target effects and 
created fragments of about 200 bp. 
Primers 
Primer name Primer Sequence 
Forward Chr1 TTCCTCCTGGATACTCCCGTGGCT  
Reverse Chr1 AAGCAGGACACCCATCCCTGC 
Forward Chr4 CAGATTTGAGATGTAGTCCTGTG 
Reverse Chr4 CTAATCTTACGAAAATGGAACACTG 
Forward Chr5 GACATGACAACTAAATGCAATGTAC 
Reverse Chr5 ATGTTCATATCCTAACTCCCAGAGTC 
Forward Chr9 GCTACTGCCTTGATTCACAATGC 
Reverse Chr9 ATTAGGATGATGGAATCATAGGCC 
Forward Chr12 ATGGCTGTGTTGGTGATGAGG 
Reverse Chr12 GTAATATCCAGTGTCTATCTTCC 
Forward Chr14 GGCTCTGCTCACTCCACAAGTC 
Reverse Chr14 TTACAAGTGTAGAGTCACCTCTG 
 
PCR Protocol 
Component Concentration Amount 
Forward  10 pmol/µl 2.5 µl 
Reverse  10 pmol/µl 2.5 µl 
Phusion GC Buffer 5x 10.0 µl 
Phusion DNA 
Polymerase 
2U/µl 0.5 µl 
DMSO  2.5 µl 
dNTPs 2.5 mM each 2.0 µl 
H2O  29.0 µl 
Template DNA  1.0 µl 
 
Cycling Parameters 
Step Temperature Time 
1 98 °C 3 min 
2 98 °C 30 sec 
3 58 °C for 4 and 12 
62 °C for 1,5,9 and 14 
20 sec 
4 72 °C 20 sec 
Cycle back to Step 2 30 times 
5 72 °C 5 min 
6 12 °C ∞ 




Data were collected from 2–9 independent human iN autaptic cultures 
to account for putative culture to culture variability. Independent human iNs 
cultures were generated by an individual induction process from each human 
iPSC line for each replicate. For electrophysiological experiments, an equal 
number of recordings per experimental group in each replicate culture were 
obtained.  
Statistical significance was determined by using the two-tailed Mann 
Whitney test for unpaired data at the given significance level (*p < 0.05, **p < 















Autaptic culture of human induced neurons   
The properties of iPSC lines generated by different methodologies can 
vary extensively (Bardy, van den Hurk et al. 2016). To ensure that INs obtained 
from iPSCs could generate autaptic human iNs, cultures independently of the 
origin or the methodology used for the iPSC generation, we used two 
independent iPSC lines provided by the Berlin Institute of Health Core Facility 
Stem Cells (Berlin, Germany): the iPSC line BIHi001-A derived from human 
foreskin fibroblasts using Sendai virus vectors and the iPSC line BIHi004-A 
derived from human fibroblasts using episomal vectors. 
 In initial experiments, we differentiated iNs from iPSCs by 
overexpression of NGN2 to obtain a pure glutamatergic neuron population for 
the production of autaptic cultures using the protocol described by Zhang and 
colleagues (Zhang, Pak et al. 2013). Human iNs mass cultures were then 
dissociated at day 4 post induction (DPI) and plated directly onto mouse-
derived astrocytic microislands at a density of 4 K cells per 6 Well to allow 
them to grow independently on single islands. Using this approach, after 6 
weeks in autaptic culture human iNs showed very low survival, not suitable for 
electrophysiological or morphological characterization required to validate this 
protocol. Shorter cultivation times on the autaptic islands led to a lack of 
measurable synaptic transmission. The survival rate of neurons until the time 
of measurable synaptic activity was so low, far below one percent, that even 
an increase of the initially seeded human iNs would not have led to a sufficient 
result. However, the few measured synaptic responses from the surviving 
human iNs did not differ in their physiological or morphological parameters 
from those in the new protocol developed in the following study. It should be 
noted, though, that due to the small sample number (n) no statistical statement 
can be made. The low survival rate of the human autaptic iNs can be explained 
by the observation that astrocytic microislands rarely remained healthy for 
longer than 4 weeks, limiting the overall time in vitro of the autaptic iNs. 




require a period of significant cell-to-cell contacts with other neurons in order 
to mature sufficiently like it is seen in normal mass cultures. 
We therefore used the differentiation protocol by Zhang and colleagues 
to obtain human iNs and created a different two phased protocol to produce 
the autaptic human iNs cultures. In the first phase we allowed the human iNs 
to develop within the network of mass culture. To support neuronal survival on 
day 4 we added mouse astrocytes on top of the human iNs as described by 
Zhang and colleagues. Despite the fact that human iNs grew extensive 
neurites during the first phase, we were able to efficiently dissociate them for 
replating. In the second phase, human iNs were plated on astrocytic 
microislands, subsequently cultured and allowed to grow for another 14 to 21 
days before they were used for morphological and functional characterization 
(Figure 3 A).  
We observed that the duration of phase I played an important role to 
successfully obtain electrophysiological responses in the autaptic human iNs. 
To determine the optimal time point needed for the human iNs in phase I, we 
performed a timeline experiment, in which we kept the human iNs 14, 35 and 
60 days in the first phase before we replated them onto the microislands. 
Following another 14 to 21 days onto microislands, we performed whole-cell 
patch-clamp recordings in order to examine the passive and active membrane 
properties of autaptic human iNs (Figure 3 B). Regardless of the time of human 
iNs in phase I all autaptic human iNs developed voltage-dependent sodium 
and potassium currents and robust AP firing. In contrast, only 44 % of the 
autaptic human iNs exhibited spontaneous release (mEPSC) at 14 and 35 
days in phase I. In line, only 14.3 % of the autaptic iNs being 14 days in 
phase I, showed evoked NT release (EPSC) and 32 % at 35 days. For human 
iNs being 60 days in the first phase, an average of 80 % of the cells showed 
both spontaneous and evoked NT release (Figure 3 B). Longer periods in the 
first phase did not result in a significant difference compared with the 60 day 
time point (data not shown). Therefore, we defined 60 days in phase I as the 
necessary time point when synaptic transmission can be reliably measured to 








Figure 3: Human neurons in autaptic culture 
A) Schematic diagram of the autaptic culture protocol for human iNs. IPSCs were plated and 
infected with NGN2, rtTA and eGFP on day –1, followed by application of doxycycline to start 
Ngn2 expression and puromycin selection on day 0 to 3. Mouse astrocytes were added on 
day 3 and co-cultured for 60 days, followed by dissociation with Accutase and replating onto 
astrocytic microislands. Single autaptic iNs were analysed after additional 14-21 days on 
microislands feeder cultures. B) Quantification of electrophysiological recordings of autaptic 
iNs replated on microislands after 14, 35 or 60 DPI in the mass-culture phase I, followed by 




Morphology of human iNs in autaptic cultures  
We first assessed whether human autaptic iNs generated with our new 
protocol possessed the same general morphological characteristics as 
glutamatergic autaptic neurons obtained from murine hippocampi. We 
determined the following morphological parameters in the autaptic human iNs, 
length of dendrites and axons and the number of synapses, by applying 
immunocytochemical methods. Quantitative analysis of MAP2 -positive 
neurites showed that the dendritic trees were shorter, compared to murine 
hippocampal neurons (Sampathkumar, Wu et al. 2016), with mean lengths of 
377 ± 83 µm and 253 ± 35 µm for iNs derived for the BIHi001- and BIHi004- 
iPSC lines, respectively (Figure 4 A). Axonal length, determined by the mixture 
of monoclonal antibodies that react against complex network proteins of axons 
(SMI 312), showed that the human iNs axons’ reached 4.5 ± 0.6 mm and 
3.0 ± 0.3 mm in BIHi001- and BIHi004- derived iNs, respectively (Figure 4 A). 
Interestingly, these axons are 50 - 250% longer than those of primary mouse 
hippocampal neurons in autaptic culture (Sampathkumar, Wu et al. 2016). 
 After determining the dendritic and axonal lengths, we quantified the 
synapse number and density of the autaptic human iNs by counting 
synaptophysin-positive puncta distributed along the MAP2-positive dendrites 
(Figure 4 B). Synapse densities were 26 ± 3 and 42 ± 3 per 100 µm in the 
human iNs derived from BIHi001- and BIHi004- iPSC lines, respectively, while 
the total synapse number for the human iNs derived from BIHi001- and 
BIHi004- iPSC lines were 98 and 106 synapses per cell, respectively. Synapse 
densities were comparable to those of rodent neurons in autaptic culture 











Figure 4: Morphological analysis of human induced neurons in autaptic culture 
A) Representative images and quantification of total axonal and dendritic lengths of human 
autaptic iNs. Dendrites were identified by MAP-2 staining and axons were stained with SMI-
312. Images in each row belong to the same iN lines. Scale bars: 50 µm. B) Example images 
and quantification of synapse density in human autaptic iNs. Synapses were identified by 
Synaptophysin labelling. Only Synaptophysin punctae (red) on top of MAP-2 staining (blue) 
were counted. Scale bars: 5 µm. The numbers of human INs and independent cultures 




Passive membrane properties and ion channel characteristics 
After assessing morphological features, we wanted to examine 
functional properties of the autaptic human iNs. We used current-clamp 
experiments to demonstrate the ability to fire AP and showed that upon 
injection of 20 pA iNs started to show robust AP firing. The number of APs 
increased constantly with an increase in injected current. The two cell lines 
exhibited no significant differences. (Figure 5). 
We next performed whole-cell current and voltage-clamp recordings in 
order to examine their passive and active membrane properties (Figure 5). 
Both human autaptic iNs derived from BIHi001- or BIHi004-iPSC lines had 
similar resting membrane potentials of approximately -55 mV. Additionally, 
both lines presented same input resistances of approximately 375 MW and 
showed comparable membrane capacitances around 30 pF (Figure 5 A). 
Furthermore, all autaptic iNs recorded showed voltage-dependent sodium and 
potassium currents (Figure 5 B, also see Figure 6 A).  
 We quantified excitatory (Glutamate) and inhibitory (GABA) NT receptor 
functionality in our human iNs by exogenous application of the respective 
agonists (Figure 5 D). Application of kainic acid (20 µM), an agonist of the 
kainite-class ionotropic glutamate receptors, elicited a mean current density of 
approximately 10 pA/pF, indicating the presence of functional glutamate 
receptor. In contrast, application of the aminoacidic derivative NMDA (100 µM) 
yielded negligible currents, indicating poor expression of NMDA-type 
glutamate receptors. However, direct application of the GABA aminoacid  
(5 µM) led to robust responses in all iNs tested (Figure 5 D) proving the 
existence of functional GABA ionotropic receptors (GABAA). While the two 
human autaptic iNs derived from the different lines varied in mean current 
density (BIHi001, 92.9 ± 12.6 pA/pF and BIHi004, 62.9 ± 11.9 pA/pF), these 
results indicate the presence of AMPA and GABA receptors in human autaptic 






Figure 5: Passive membrane properties and ion channel characteristics of iNs grown in 
autaptic culture 
A) Average resting membrane potential, input resistance and membrane capacitance of 
human autaptic iNs. B) Representative whole-cell voltage-clamp traces (left) and quantitative 
analysis of Na+/Ca2+ and K+-currents (right) measured with whole-cell voltage-clamp. 
C) Representative traces (left) and quantitative analysis of the number of APs per second 
elicited by current injections in current-clamp recordings (right). D) Quantification of 
postsynaptic currents evoked by application of either 20 µM kainic acid (left), 100 µM NMDA 
(middle) or 5 µM GABA (right) in the presence of 10 µM glycine and in the absence of Mg2+. 
The numbers of neurons and independent cultures analysed are shown within the bars. Data 







Neurotransmission in autaptic human iNs  
Since we observed robust synapse formation and functional 
postsynaptic receptors for AMPA, we next assessed functional properties of 
autaptic human iN synapses by whole-cell voltage-clamp recordings. Upon a 
2 ms somatic depolarization to induce an evoked AP, a large majority of the 
human iNs (85 %) responded with a rapidly decaying synaptic inward current, 
demonstrating the high efficiency of the culture protocol (60 days phase I +  
14-21 phase II) for generating functional and mature autaptic human iNs. The 
synaptic responses recorded confirm the existence of neurotransmitter release 
and the functionality of the postsynaptic receptors. (Figure 6 A). The 
postsynaptic inward currents were robust with mean amplitudes of 
1.1 ± 0.2 nA and 1.0 ± 0.1 nA for BIHi001- and BIHi004- derived human iNs, 
respectively (Figure 6 B). Application of the AMPA receptor antagonist NBQX 
quantitatively blocked the postsynaptic currents, confirming the glutamatergic 
phenotype of the release and that most of the postsynaptic current was carried 
by the AMPA receptors. On a side note, the time between the AP induction 
and postsynaptic response was more variable (data not shown) than in murine 
autaptic cultures, which we attributed to more extensive axonal outgrowth in 






Figure 6 Action potential-evoked neurotransmitter release 
A) Fraction of neurons which showed membrane voltage-dependent K+ and Na+/Ca2+ 
currents, EPSC and mEPSC in autaptic human iN cells. B) Representative traces of AP-
evoked EPSCs recorded in the absence or presence of the AMPA receptor antagonist NBQX. 
C) Mean AP-evoked EPSC amplitudes of iNs induced from BIHi001- and BIHi004-iPSCs. AP 
artefacts were blanked and are indicated by black arrows. The numbers of neurons and 
independent cultures analysed are shown within the bars. Data are expressed as mean ± SEM. 
 
 
One of the major advantages of the single cell autaptic culture system 
is that it allows for the quantification of the RRP, which is a product of the 
number of fusion-competent vesicles in all synapses of a given neuron. One 
way by which the RRP can be assessed is by the application of a pulse  
(5 seconds) of a hypertonic sucrose solution onto the neurons using a fast-
flow perfusion system (Rosenmund and Stevens 1996). The sucrose 
application results in a postsynaptic inward current that represent the release 
from all fusion competent synaptic vesicles (RRP). The charge of the sucrose-
evoked current can be quantified by integrating this current transient  
(Figure 7 A) and thus estimating the RRP. The mean RRP charges were 
50 ± 10 pC and 67 ± 11 pC for BIHi001- and BIHi004- derived iNs, 
respectively.  
In the absence of stimulation, we recorded spontaneous 
neurotransmitter release indicated by mEPSCs (Figure 7 B). The mean 
mEPSC amplitude was significantly smaller in BIHi004- compared to BIHi001-
derived human iNs (Figure 7 C; BIHi001: 39.7 ± 2.4 pA; BIHi004: 
30.4 ± 2.8 pA, Mann-Whitney U test, p = 0.0024). However, spontaneous 




(Figure 7 B). Using the average mEPSC charge and the RRP charge, we 
calculated the total number of SVs in the RRP. BIHi001-derived human iNs 
had an average of 618 ± 97 vesicles in the RRP (Figure 7 D). In contrast, for 
BIHi004-derived iNs the average number of vesicles in the RRP was 
869 ± 113. We could estimate the number of SVs in the RRP per synapse from 
the average number of synapses per cell. This resulted in an average of 6.2 
fusion-competent SVs per synapse for BIHi001 and 8.2 fusion-competent SVs 
per synapse for BIHi004.  
 Knowing the RRP and the action potential-evoked EPSC charges we 
determined the fusion efficiency of individual fusion-competent vesicles by 
calculating the (PVR). PVR is the likelihood that a given synaptic vesicle is 
released in response to an action potential. We found that the PVR was  
14.2 ± 2.3 % and 11.1 ± 2.1 % in BIHi001- and BIHi004-derived iNs, 
respectively (Figure 7 E).  
We also calculated the spontaneous release rates of individual fusion-
competent vesicles by normalizing the mEPSC frequency (Figure 7 B) to the 
RRP size (Figure 7 E). Human iNs had a surprisingly high spontaneous 
release rate compared with mouse hippocampal neurons (Arancillo, Min et al. 
2013) but comparable to thalamical neurons (Albright, Weston et al. 2007), 
where 0.8 ± 0.1 % and 0.5 ± 0.2 % of the RRP is turned over within a second 






Figure 7 Pool size and spontaneous neurotransmitter release 
A) Exemplary trace of the synaptic response of an autaptic iN elicited by 500 mM hypertonic 
sucrose solution (left) and average size of the RRP charges (right B) Exemplary mEPSCs 
recorded from autaptic iNs in the absence or presence of NBQX (left) and mean mEPSC 
frequencies of human autaptic iNs derived from the BIHi001- and BIHi004 iPSC lines (right). 
C) Mean amplitudes and charges of mEPSCs. D & E) Number of SVs in the RRP (D) and mean 
PVR (E). F) Spontaneous release rate of human autaptic iNs. The numbers of human iNs and 
independent cultures analysed are shown within the bars. Data are expressed as mean ± SEM. 




Another way to determine the release probability is to look for facilitation 
or depression of the postsynaptic currents under a series of multiple 
stimulations. For this purpose we used a 40 Hz paired pulse stimulation 
protocol (25 ms ISI, Figure 8 A) and a protocol with a train of 50 AP at a 
frequency of 10 Hz (10 Hz 50 AP, Figure 8 B). In both cases we could see a 




Figure 8 Short term plasticity 
A) Average paired-pulse ratios (PPR) calculated from two EPSCs with an ISI of 25 ms. B) 
Normalized EPSC amplitudes during a 10 Hz train stimulation. The numbers of human iNs and 






Postsynaptic responses are mediated by AMPA receptors 
We next examined the glutamatergic receptor composition and 
assessed the relative contribution of each receptor type to synaptic 
transmission at the human iN postsynapse. We utilized specific antagonists for 
AMPA (NBQX; 3 µM) and NMDA receptors (D-AP5; 10 µM). The results 
showed slight differences between the iN lines. While BIHi001-derived iNs 
indicated no evidence of NMDA receptor - mediated synaptic transmission, 
BIHi004-derived iNs showed around 5 % contribution of NMDA receptors to 
EPSC amplitudes (Figure 9). These data demonstrated that autaptic human 
iNs contains a robust expression of AMPA receptor but a general deficiency of 
NMDA receptor expression, consistent with our results obtained from 
exogenous application of AMPA and NMDA receptor agonists (Figure 5 D).  
 
 
Figure 9: AMPA/NMDA ratio in iN  
Components of the EPSCs mediated by AMPA and NMDA receptors. AP artefacts were 
blanked and are indicated by black arrows. The numbers of neurons and independent 






Modulation of glutamate release by metabotropic receptors and 
phorbol esters 
In a next step, we assessed how release from human glutamatergic 
synapses is modulated by well-known modifiers of release. First, we applied 
the GABAB agonist Baclofen (20 µM), which is known to robustly inhibit release 
of excitatory glutamatergic synapses (Scanziani, Capogna et al. 1992). 
Indeed, we found that Baclofen rapidly and reversibly reduced EPSC 
amplitudes by 69 % and 77 % in BIHi001- and BIHi004- derived iNs, 
respectively (Figure 10 A). These results demonstrate that the human iNs 
express presynaptic GABAB receptors and efficiently couple them to the 
release apparatus. 
We also examined metabotropic glutamate receptor (mGluR) 
modulators and noticed that 1µM DCG-IV, an agonist for type II mGluRs, 
significantly reduced Ca2+ evoked synaptic transmission in human autaptic iNs 
(9.2 % in BIHi001-derived iNs; 7.4 % in BIHi004-derived iNs; Figure 10 B). 
Nevertheless, only BIHi004-derived iNs responded to activation of type III 
mGluRs by the agonist L-AP4 (30 µM) with a small but significant reduction of 
EPSC amplitudes by 12 % (Figure 10 C). 
Finally, we examined the synaptic response potentiation by phorbol 
esters, which are known to modulators of vesicle fusogenicity through 
activation of the Munc13 family of proteins (Rhee, Li et al. 2005, Basu, Betz et 
al. 2007). Application of 1 µM of the phorbol ester PDBu rapidly increased the 
evoked responses, plateauing at 123 % and 142 % in BIHi001- and BIHi004- 
derived iNs, respectively (Figure 10 D). The overall degree of potentiation was 
modest, consistent with the high initial release probability (Figure 7) (Basu, 






Figure 10: Modulation of glutamate release by metabotropic receptors and phorbol 
esters 
A) Comparison of EPSC amplitudes with and without Baclofen, DCG-IV (B) and L-AP4 (C). 
D) EPSC potentiation by application of PDBu. AP artefacts were blanked and are indicated 
by black arrows. The numbers of neurons and independent cultures analysed are shown 







Unc13A KD abolishes RRP of vesicles and NT release 
One of our main goals behind the development of the autaptic human 
iN model system was to reliably study the neurotransmission process in human 
neurons. To validate the reliability and reproducibility of our system, we also 
aimed to investigate this process in the absence of one of the essential 
elements of the NT release machinery, the docking/priming factor Unc13. For 
this reason, we genetically modified the human iNs after replating using a 
shRNA-based KD assay for Unc13A. Lentiviral transduction of Unc13A-
specific shRNA in iNs led to a nearly complete loss of Unc13A protein levels 
assayed by western blot of lysates of 14 DIV mass-cultured human INs 
replated after 60 days in phase I (Figure 11 A). Knocking-down Unc13A in 
autaptic human iNs resulted in a complete absent of evoked NT release 
(Figure 11 B). Furthermore, in these human iNs no measurable RRP could be 
detected by application of hypertonic sucrose solution (Figure 11 C). These 
results validate our model and demonstrate, that human Unc13A has an 
indispensable role in the priming step of the NT release in the human INs, as 
it has been observed in mouse loss-of-function models for Munc13-1 






Figure 11: Loss of function by knocking down Unc13A in BIHi001. 
A) Immunoblot of Unc13A protein levels of mass culture human iNs transduced with a shRNA 
against Unc13A or a control construct. Signal at 200 kDa corresponds to Unc13A, and the 
signal at 50 kDa to β-Tubulin. Western blot images have been cropped for better illustration. 
B) Exemplary traces of AP-evoked EPSCs (left) and average EPSC amplitudes (right) in 
Unc13A KD and control (CTL) conditions of BIHi001 cells. C) Exemplary traces of currents 
evoked by 500 mM hypertonic sucrose solution (left) and average sizes of the RRP charges 
(right). (ND, not detectable). AP artefacts were blanked and are indicated by arrows. The 
numbers of human iNs and independent cultures analysed are shown within the bars. Data 








Generation of a constitutive KO for Synaptotagmin 1 by 
CRISPR/Cas9 
IPSC have a high potential to represent models of pathophysiological 
diseases of the CNS and have the power to better reflect the human phenotype 
compared to transgenic animal models. With the help of CRISPR/Cas9, 
genetic defects can be imitated in healthy donor cells or repaired in diseased 
lines. This will serve us after the generation of autaptic human INs, together 
with a lentiviral rescue approach, as an ideal tool for in vitro disease modeling 
to study the effects in the human neurotransmission process of mutations in 
genes encoding synaptic proteins.  
Synaptotagmin 1 (Syt1) has been described as the main Ca2+ sensor 
for neurotransmitter release and a Syt1 KO mice have been well characterized 
as a model to study synchronous release (Fernandez-Chacon, Konigstorfer et 
al. 2001, Chang, Trimbuch et al. 2018). Additionally, known genetic mutations 
in human Syt1 gene have been associated with the neurodevelopmental 
disorder Baker Gordon syndrome, making it a very interesting model protein 
to test in our iNs (Baker, Gordon et al. 2015, Baker, Gordon et al. 2018). To 
study possible defects in neurotransmission in the Baker Gordon syndrome 
we attempted to produced autaptic human iN cultures generated from a 
homozygous KO iPSC line for the presynaptic protein Syt1.  
 For the generation of a constitutive KO for Syt1 in human iPSC we 
decided to produce a frame shift in exon 5, which translates for the beginning 
of the transmembrane domain, using CRISPR/Cas9. This is predicted to result 
in an early stop codon that disrupts the translation of Syt1 and causes the 
elimination of Syt1. The four highest ranked sgRNAs, as predicted by 
bioinformatic tools (see material and methods), were used for the generation 
of the constitutive KO (Figure 12 A). After a further validation of the efficiency 
for the production of insertions or deletions to the DNA we decided to continue 
with sgRNA#1 as it scored highest in the prediction to generated a Syt1 KO 
(Figure 12 B). Using sgRNA#1, we targeted exon 5 in our BIHi005 iPSC line 




over the on-target region we selected 6 clones (clones 2, 7 ,30, 31, 40 and 59). 
We confirmed that the 6 clones had stop codons at different positions of exon 
5 and that the stop codons were always at the beginning of the area 
corresponding to vesicular transmembrane domain, except for clone 2. The 
stop codons were generated either by insertion of 2 bases in case of clone 7 
or by deletions of 1 to 25 bases for the other clones (Figure 12 C). 
 
 
Figure 12 Guide RNA design and evaluation 
A) Table showing the 4 top scored sgRNA used for Nucleofection. B) Summary of KO score 
validation by bioinformatic analysis (ICE from Sythego). C) Scheme of Syt1 Protein and the 
location of exon 5. Red bars indicating insertion of stop codon from the different clones after 
clonal selection. 
 
The 6 clones were further examined for their clonality using next 
generation sequencing. A PCR fragment spanning a 250 base pair area over 
the edited site was sequenced using the Illumina Platform. After filtering, a total 
of about 60000 reads were obtained and compared to the unedited wild type 
(WT) sequence. The clonality was confirmed for the top 6 clones (Figure 13 
A). To narrow down the number, we decided to continue with clone number 7 
and 59. In clone number 7, the stop codon occurred at the amino acid positions 
61 by an insertion of 2 bases and in clone number 59 the stop codon occurred 
at position 58 due to a deletion of 25 bases. This means that for both clones 




the remaining fragment length is about 6 kDa. Karyograms of the 2 clones 
were obtained and revealed no abnormalities regarding the chromosome set 
or the morphology of the individual chromosomes indicating no additional 
chromosomal abnormalities in the clones (Figure 13 B). Predicted potential off 
target regions of our sgRNA#1 were checked by Sanger sequencing clone 7 
and 59. Analysis of the sequences spanning off target regions on chromosome 
1, 4, 5, 9, 12 and 14 (for details see material and methods) could not detect 
any changes in the DNA. 
 
 
Figure 13 Quality control of generated clones 
A) Results of amplicon sequencing validating clonality of all 6 clones in comparison to WT.  






Synaptic transmission in human Syt1 deficient neurons 
After we established the human INs Syt1 KO, we used the culture 
protocol developed above to perform western blots from mass cultures and 
electrophysiological measurements in autaptic human iNs. 
To ensure that all observed effects were caused by the loss of Syt1 we 
used two different clones namely clone 7 and 58. A western blot using an 
antibody against the c terminus of Syt1 showed the complete loss of the 
protein in mass cultured neurons of both Syt1 KO clones. Employing 
electrophysiological recordings, we found a dramatic loss of evoked AP 
neurotransmitter release. This was reflected by the reduction of the EPSC 
amplitude by 90 % for clone 7 and 87 % for clone 59. The reduction of 40 % 
for both clones of the EPSC charge integrated for 1 s (Figure 14). This data 
was consistent with the loss of asynchronous release observations detected 
in the Syt1 KO mouse model. However, the reduction of the EPSC charge was 









Figure 14 Evoked responses of Syt1 KO neurons 
A) Western blot from mass cultured human iNs showing the loss of Syt1 in clone #7 and clone 
#59 (arrow, expected band at 65 kDa). B) Representative traces of AP-evoked EPSCs from 
WT (black) or Syt1 KO (red and blue) human INs. C & D) Mean AP-evoked EPSC amplitudes 
(B) and charges (C) of iNs from both KO clones in comparison to their corresponding WT CTL 
cell line. The number of neurons and independent cultures analysed are shown within the 







Application of 500 mM sucrose to measure the RRP independent of 
calcium influx revealed, that the total RRP was not significantly reduced in the 
Syt KO iNs clones. However, the release probability of AP evoked vesicle 
fusion was reduced by approximately 50 % (Figure 15 A, B) whereas the 
mouse model showed a stronger reduction of about 80 % (Xue, Ma et al. 
2008).  The reduced PVR was also reflected when we applied short term 
plasticity protocols. When human iNs were stimulated with two depolarizing 
pulses with an ISI of 25 ms, both Syt1 KO human iNs clones show a stronger 
facilitation of the second EPSC amplitude, approximately 3 times compared to 
the WT iNs that cause a depression of the second EPSC of about 20 %. 
(Figure 15 C). This data correlate with the lower vesicular release probability 
of 11.4 % for clone 7 and 11.8 % for clone 59 compared to the WT with  
25.8 %. Under sustained stimulation at synapses with low vesicular release 
probability, calcium accumulates at the release sites, increasing the release 
probability of the vesicles that facilitates the following evoked responses. This 
was observed in both clones upon stimulation at 10 Hz for 5 seconds (Figure 
15 D). 
Using unstimulated traces and looking for spontaneous NT release we 
could not find any significant differences neither for the frequency nor for the 






Figure 15 Release probability of Syt1 KO neurons 
A & B) Number of SVs in the RRP (A) and mean PVR (B). C) Average paired-pulse ratios (PPR) 
calculated from two EPSCs with an ISI of 25 ms. D) Normalized EPSC amplitudes during a  
10 Hz train stimulation. E) Mean mEPSC frequencies of Syt1 KO neurons in comparison to 
their WT CTL. The numbers of neurons and independent cultures analysed are shown within 






 Even though we used two individual Syt1 KO clones, there is still the 
possibility that the observed phenotypes are due to off target mutations. To 
rule out that possibility, we used lentiviral transduction to express the full-
length cDNA of Syt1 to see if we could restore the Syt1 protein levels and 
obtain the WT phenotype. Since we could not depict any major differences 
between clone number 7 and clone number 59, we decided to perform these 
experiments only with clone number 7. Lentiviral transduction to reintroduced 
the protein was performed 24 h after splitting the cells on autaptic feeder 
islands, followed by a further cultivation for 14 to 21 days before performing 
the electrophysiological recordings. 
The evoked response was rescued to 70 % compared to the WT CTL 
with no significant difference between this groups (Figure 16 A, B). The other 
two main phenotypes observed in the Syt1 KO were the reduced PVR and 
increased STP. Short-term plasticity for the KO showed a strong facilitation in 
the PPR and the 10 Hz stimulation over 5 seconds. With the reintroduction of 
the full length cDNA we see the same depression in 10 Hz and PPR as for the 
corresponding WT control (Figure 16 C, E). Additionally, Pvr was restored to 
the level of WT, by reintroduction of Syt1 (Figure 16 D). These results confirm 
that our Syt1 KO is both specific and functional. In addition, it demonstrates 






Figure 16 Syt1 KO can be rescued by reintroducing human cDNA 
A) Mean AP-evoked EPSC amplitudes showing significant reduction for the KO and through 
lentiviral overexpression, the restoration of WT level. B) Mean AP-evoked EPSC charge 
showing a trend for a reduction for the KO and no difference for the rescue construct  
C) Average paired-pulse ratios (PPR) calculated from two EPSCs with an ISI of 25 ms  
D & E) Mean PVR showing the lower release probability for the KO which correlate with the 
facilitation during the 10 Hz train (E) and PPR (C) and through lentiviral overexpression, the 
restoration of WT phenotypes for those parameters. The numbers of neurons and 

















In this study, we established the first protocol for the autaptic culture of 
human iPSC-derived neurons. We developed a two-phase protocol that was 
validated on different iPSC cell lines. This way we could reliably demonstrate 
that our method robustly generates mature human neurons, that are capable 
to grow in isolation on astrocytic microislands and form functional synapses 
onto themselves. The morphological and functional properties of these human 
induced neurons and their synapses are accessible to highly quantitative 
analysis. Hence, our approach allows future analysis of drug- or genetically 
induced phenotypes with higher precision whilst offering more sophisticated 
methods of analysis than what is currently possible with culture methods. 
Additionally, we successfully modified gene expression using two different 
approaches in the autaptic human iN leading to major changes in the recorded 
synaptic properties. In a first step, we used a shRNA based knockdown of the 
well-described Unc13 protein during the autaptic phase. In a second step, we 
developed a constitutive KO cell line for Syt1 using CRISPR/Cas9.  
 
Autaptic iNs show robust synapse formation 
 To establish autaptic cultures of human iNs we had to overcome two 
major difficulties: the limited life time of the astrocytic microislands (Emperador 
Melero et al. 2017), and the fact that human iNs do not like to exist in isolation. 
While optimizing our culture protocol we noticed that we could split mass 
cultured human iNs after 60 days, thereby circumventing both obstacles. 
Therefore, we argue that the modified culturing procedure, of splitting it up into 
two phases, still represents a precise method for the analysis of synapse 
formation, maintenance and density. 
In comparison to already known protocols for neurons differentiated 
from embryonic stem cells in mass culture, we found that the autaptic iNs had 
passive membrane properties which were comparable to previous studies 
(Zhang, Pak et al. 2013, Pak, Danko et al. 2015, Patzke, Han et al. 2015, 




and can also be transferred to those from mouse models (Mangan and Kapur 
2004). Although our culturing procedure generates neurons with relatively 
shorter dendrites than classical culturing methods, the density of synapses 
formed is comparable to other experimental approaches (Chang, Trimbuch et 
al. 2014, Sampathkumar, Wu et al. 2016, Wu, Lee et al. 2016). We do not think 
this  is specific for human iNs but rather caused by the replating or culturing 
procedure because mass-cultured iNs do have longer dendrites (Patzke, Han 
et al. 2015, Patzke, Acuna et al. 2016, Gunhanlar, Shpak et al. 2018). In 
contrast, the axonal outgrowth appears much more resilient to replating, as 
axon lengths were comparable to mass-cultured human iNs (Patzke, Acuna et 
al. 2016) and were 50 - 250 % longer than those of primary mouse 
hippocampal neurons in autaptic culture (Sampathkumar, Wu et al. 2016). The 
synapse densities were comparable to those of autaptic rodent neurons 
(Chang, Trimbuch et al. 2014, Sampathkumar, Wu et al. 2016). However, due 
to the shortened dendrites, the total synapse numbers were reduced 
accordingly. 
 
Quantitative determination of synaptic input and output function, 
and determination of synaptic efficacy 
Using the presented technique, the alterations in important synaptic 
parameters, such as release probability, can now be analyzed and compared 
in a more comprehensive quantitative manner. The functional properties of the 
autaptic iNs were overall consistent with the mass-cultured iNs described by 
Zhang and colleagues, which also showed a lack of NMDA receptor 
expression (Zhang, Pak et al. 2013). However, our recorded synaptic 
responses were much larger than those measured in mass culture (Zhang, 
Pak et al. 2013, Pak, Danko et al. 2015, Patzke, Han et al. 2015, Yi, Danko et 
al. 2016). Depending on the presynaptic stimulation technique (e.g. paired 
recordings, field stimulation) the responses in mass culture only reflect a small 
and highly variable fraction of the synaptic input onto the recorded 




synapses stimulated is strongly dependent on the geometry of the electrical 
field generated by the stimulator. Furthermore, the input derives from multiple 
presynaptic neurons. On the other hand, the autaptic culture system has the 
unique advantage that inputs are monosynaptic and originate all from the 
same neuron, explaining our observed larger synaptic responses compared to 
published mass culture recordings. Additionally, the autaptic culture systems 
allows for quantitative assessment of the total synaptic input and output of a 
given neuron with a single AP stimulation. Still, when we compare our synaptic 
responses with those recently published in human autapses from other 
laboratories, our responses were up to 5 times smaller (Meijer, Rehbach et al. 
2019, Rhee, Shaib et al. 2019). This can be explained by the fact that all 
synaptic responses with EPSC amplitudes smaller than 500 pA were removed 
from the statistics in Meijer et. al (Meijer, Rehbach et al. 2019). These strict 
exclusion criteria make it difficult to study models in which the EPSC amplitude 
is smaller than in WT due to the phenotype. Therefore, we decided to include 
all data points in our analysis. 
Combined functional and morphological analysis in the autaptic human 
iNs is particularly suitable for describing the properties of individual human 
synapses in greater detail. We observed, for example, that the number of 
easily releasable SVs per synapse ranged from 5 to 10 vesicles per nerve 
ending, a value similar to that reported in rodent hippocampal neurons 
(Schikorski and Stevens 1997, Murthy, Schikorski et al. 2001). Computation of 
release probability and spontaneous release rates indicated that human iN 
vesicles display a rather high fusogenicity, reminiscent of high release 
probability glutamatergic neurons in the sensory pathways, such as thalamic 
(Albright, Weston et al. 2007, Weston, Nehring et al. 2011) and layer 4 cortical 
neurons (Feldmeyer 2012). High vesicle fusogenicity is also consistent with 
the moderate potentiation by PDBu application (Figure 10) (Basu, Betz et al. 
2007, Shin, Lu et al. 2010). The mechanism for the rather high fusogenicity is 
unknown, but may relate to the expression of the VGLUT subtype 2 (Zhang, 
Pak et al. 2013), which is known to be associated with intrinsically higher 




Assessment of modulation of synaptic responses by exogenous 
modifiers of synaptic transmission 
 Presynaptic metabotropic receptors and their associated second 
messenger systems play an important role in proper neuronal and brain 
function (Huang and Thathiah 2015). Modulation of NT release by the 
activation of presynaptic metabotropic receptors is a common target in drug 
development and treatment of several neuropsychiatric disorders (Miyamoto, 
Miyake et al. 2012, Aleman, Lincoln et al. 2017, Bruno, Caraci et al. 2017). 
The identification of the particular set of metabotropic receptors expressed by 
human iNs is therefore particularly important. At the same time, assessment 
of the modulation of NT release by second messenger systems requires 
reliable quantification of evoked synaptic responses, which is the major 
advantage of the autaptic cell culture system. Using our autaptic culture 
system for human iNs, we showed for the first time, that synaptic transmission 
of these neurons is reliably modulated by GABAB and metabotropic glutamate 
receptors. 
 
Modification of gene expression in individual neurons, enabling 
loss of function and mutational studies in the human biological 
background 
Over the last few years analysis of the human genome has revealed 
numerous genetic mutations related to pathophysiological changes in 
neuronal development and brain function. Understanding the basic 
mechanisms of these mutations has been studied exclusively in animal 
models, especially in mice (Hofker, Fu et al. 2014). Cutting-edge 
developments in genetic methods and stem cell programming for the first-time 
can provide direct access to human genetically modified neurons, offering a 
potential alternative to animal models. Therefore, we wanted to test if we could 
recapitulate the loss of function phenotype of UNC13A in rodent neurons to 




We demonstrated that using shRNA-based KD assays during replating 
is sufficient to generate loss-of-function models for synaptic proteins. The KD 
of Unc13A recapitulated the complete disruption of synaptic NT release in 
Munc13-1/2  double KO rodent neurons (Varoqueaux, Sigler et al. 2002). 
Hence, our described two-phase protocol for autaptic iNs is especially flexible 
for protein structure-function experiments and modelling of human diseases. 
With the KD assay it is sufficient to keep one or two lines of wildtype iNs during 
the mass-culture phase, which can then be used for lentiviral transduction of 
shRNA, to study different protein functions during the autaptic culturing phase. 
First, we demonstrated the ability to acutely knock out proteins with 
shRNA, we then went a step further. Neurons generated from patient-derived 
human iPSCs hold great promises for the detection of synaptopathies, which 
are thought to be the basis of many human neuropsychiatric and neurological 
diseases. In conjunction with in situ genome editing, it allows for a simpler 
identification and analysis of developmental, morphological and/or functional 
aspects of putative pathophysiological mechanisms (Chao, Zoghbi et al. 2007, 
Priller, Dewachter et al. 2007, Chao, Chen et al. 2010, Weston, Chen et al. 
2014, Sampathkumar, Wu et al. 2016, Lipstein, Verhoeven-Duif et al. 2017). 
Since the genetic background of patient derived human iPSC is not fully 
understood, we used CRISPR/Cas9 to generate a constitutive KO which can 
be used to study patient-related mutations by lentiviral overexpression of the 
mutated protein of choice. We decided to use Syt1, a well-studied protein in 
the mouse model (Brose, Petrenko et al. 1992, Geppert, Goda et al. 1994, 
Xue, Ma et al. 2008, Chang, Trimbuch et al. 2018), which is associated with 
neuronal developmental disorders (Baker, Gordon et al. 2015, Baker, Gordon 
et al. 2018, Bradberry, Courtney et al. 2020). For this purpose, we targeted 
exon 5 of Syt1 and introduced a premature stop codon, leading to the loss of 
the protein, by means of RNP complex and non-homologous end joining. The 
advantage of this method is that the introduction of the synthetic RNA and the 
Cas9 protein only leads to minimal OFF targets effects because the whole 




The examination of the KO of Syt1 showed that the synchronous NT 
release was impaired in these neurons. This can be explained by the fact that 
the vesicular protein Syt1 is a Ca2+-binding protein, which is responsible for 
fast and synchronous fusion, as shown in the mouse model (Brose, Petrenko 
et al. 1992, Geppert, Goda et al. 1994, Fernandez-Chacon, Konigstorfer et al. 
2001). However, a reduction of the SV pool is only minimal. This indicates that 
the number of fusion competent vesicles is not reduced, which could be shown 
in the mouse model by both electrophysiological measurements and electron 
microscopic images (Geppert, Goda et al. 1994, Chang, Trimbuch et al. 2018). 
From this it can be concluded that the role of Syt1 as a calcium sensor alone 
has an effect on the probability of release. Syt1 KO neurons show a lower 
release probability and strong facilitation in STP. The reintroduction of the 
cDNA of Syt1 using lentivirus was able to reverse all previously observed 
phenotypes. Thus, we could show that the observed phenotype is solely due 
to the loss of the protein. This makes it possible to perform structure function 
analyses in the human autaptic culture model in the future, making it a powerful 
tool for studying disease models. 
 
Conclusion 
The availability of iPSC enables us for the first time to obtain human 
neurons from a cell culture approach and thus allows us not only to replace 
laboratory animals but also to study human diseases directly in a human 
model. Until now, this has not been possible due to the scarcity of human brain 
material and the lack of functional protocols for the quantitative analysis of 
human neuronal phenotypes. The major challenge was that cultured human 
neurons develop more slowly than mouse neurons. This is especially true for 
the maturation of synaptic transmission, which is an indicator of neural maturity 
and is a core factor of neuronal function. While mouse synapses mature in 
vitro within 2 weeks, human neurons need 6 weeks or more (Bardy, van den 
Hurk et al. 2016). For that reason, so far only mass cultured human neurons 




Yang, Chanda et al. 2017). The depth of analysis and quantification of synaptic 
properties and parameters is limited due to the complex network formed in 
mass culture. The better alternative is the single autaptic culture in which 
individual neurons grow isolated on micro-islands of astrocytes and form 
synapses exclusively with themselves. We have successfully established a 
protocol that makes it possible to obtain autaptic cultures from human iNs. With 
the presented technique the alterations in important synaptic parameters, such 
as release probability, can now be more comprehensibly analyzed and 
compared in a much more quantitative manner. Additionally, the autaptic cell 
culture constitutes a system in which function and morphology are much better 
integrated. 
While our analysis identified variations in some of the morphological and 
functional properties of the two iN lines, the overall differences were rather 
small, emphasizing the robustness and stability of our system. Moreover, the 
differences we encountered may have arisen from genetic and epigenetic 
variations within the iPSC lines (Liang and Zhang 2013). However, when using 
the technology developed in this study to model synaptic disorders, one should 
keep in mind to ensure using the correct CTL group. We show that a KO of 
Syt1 generated by CRISPR/Cas9 could be completely rescued by the 
reintroduction of the full-length protein. However, the question is whether the 
differences in physiological parameters in the initial characterization indicates 
the need for isogenic pairs. This question will need further examination. 
Currently, our analysis of the Syt1 KO cell line shows that it is a fully adequate 
replacement for the animal model. The proof of principle of this system now 
opens up new ways to study patient derived mutations and their effects on 
synaptic transmission. Furthermore, by generating knock in and deletion / 
insertions mutations using the CRISPR/Cas9 system new insights can be 
gained both in homozygote and heterozygous backgrounds. During the 
generation of a knew cell line a mixed population of homozygous and 
heterozygous clones is obtained, which makes the direct comparison of 





In principle, the described electrophysiological, pharmacological and 
immunocytochemical analyses of neuronal morphology and function can be 
extended to a two-neuron microcircuit system. This would allow the study of 
interactions between different cell types as well as mutant and wildtype cells 
(Liu, Chapman et al. 2013, Chang, Trimbuch et al. 2014, Wierda and Sorensen 
2014, Sampathkumar, Wu et al. 2016). The human autaptic culture also 
represents a powerful method for the analysis of synapse formation and 
maintenance and synapse density. In addition, this technique can be combined 
with other commonly used methods, such as calcium and vesicle pH dynamics 
imaging (Herman, Ackermann et al. 2014) or electron microscopy. This would 
allow for further analysis of the SV cycle. Finally, combining the 
electrophysiological functional analysis of disease-related phenotypes with 
Patch-Seq approach (Cadwell, Palasantza et al. 2015, Bardy, van den Hurk et 













Human iNs derived from iPSCs hold great potential for modeling human 
neurological disorders and understanding their underlying causes. Until now, 
functional analysis of human iNs has been performed in conventional mass 
culture systems. Though useful for studying iN phenotypes, conventional cell 
culture lacks the ability to quantitatively characterize developmental and 
synaptic phenotypes at the individual cell level. That can be achieved with a 
more specialized cell culture system, such as the single neuron autaptic 
culture.  
Here, we developed a two-step protocol to generate autaptic cultures of 
iPSC-derived iNs using two independent iPSC lines and a neuronal induction 
protocol based on NGN2 expression. In the first experiments we show that our 
method efficiently generates mature, autaptic iNs with normal synapse 
densities. In these human iNs we were able to measure robust spontaneous 
and AP driven glutamatergic synaptic transmission. Furthermore, the 
sensitivity of synaptic responses to modulation by agonists of metabotropic 
receptors as well as potentiation by acute phorbol ester application.  
In the second part of this work we performed an application-based 
validation of the autaptic human iNs from human iPSCs. This allowed us to 
demonstrate the reliability of our cell culture system of human iNs as a 
replacement for animal models. As a proof of principle, we first used an acute 
shRNA based knocked down of UNC 13-A. Therefore, we added the knock 
down construct during the second phase of the newly developed protocol, 
which was only 14 days prior the experimental analysis in the autaptic cultures. 
We showed that the loss of UNC13A leads to a disruption of NT release. As a 
second approach we generated a human stem cell line deficient for 
Synaptotagmin 1, combined with the lentiviral reintroduction of Syt1. Using this 
approach, we tested the sensitivity of our protocol for the generation of human 
neural microcultures through the investigation of synaptic transmission in 
comparison to the known effect in mouse models. We were able to show that 




model and could be rescued by the reintroduction of the Syt1 protein. These 
results prove the reliability as a model system for further experiments. 
We propose that the human iN autaptic culture system provides a 
versatile platform allowing for quantitative and integrative assessment of 
morphophysiological parameters underlying human synaptic transmission. 
Moreover, it can yield crucial information about developmental and functional 







Humane iNs, die von iPSCs abgeleitet sind, besitzen ein großes 
Potenzial für die Modellierung neurologischer Störungen von Patienten und 
der Untersuchung der zugrunde liegenden Ursachen. Bisher wurde die 
funktionelle Analyse humaner iNs in konventionellen Massenkultursystemen 
durchgeführt. Obwohl sie für die Untersuchung von iN-Phänotypen geeignet 
sind, fehlt es konventionellen Zellkulturen an der notwendigen 
Leistungsfähigkeit zur quantitativen Charakterisierung von Entwicklungs- und 
synaptischen Phänotypen auf der Ebene einzelner Zellen. Dies kann nur durch 
ein spezialisiertes Zellkultursystem erreicht werden, wie z.B. die autaptische 
Einzelneuronen-Kultur.  
Wir entwickelten dazu ein Zwei-Phasen-Protokoll zur Erzeugung 
autaptischer Kulturen von iPSC-derivierten iNs, unter Verwendung zweier 
unabhängiger iPSC-Linien und eines neuronalen Induktionsprotokolls, das auf 
der Expression von NGN2 basiert. In den ersten Experimenten zeigten wir, 
dass unsere Methode auf effiziente Weise voll entwickelte, autaptische iNs mit 
normaler Synapsendichte erzeugt. In diesen autaptischen humanen iNs 
konnten wir eine robuste spontane und AP-induzierte glutamaterge 
synaptische Übertragung messen. Darüber hinaus wurde die Sensitivität 
synaptischer Antworten auf die Modulation durch Agonisten von metabotropen 
Rezeptoren, sowie die Potenzierung durch akute Phorbolesterapplikation 
gemessen.  
Im zweiten Teil dieser Arbeit führten wir eine anwendungsbasierte 
Validierung der autaptischen humanen Neuronen aus humanen iPSCs durch. 
Damit konnten wir die Zuverlässigkeit unseres Zellkultursystems aus humanen 
Neuronen als Ersatz für Tiermodelle nachweisen. Als „Proof-of-Principle“ 
verwendeten wir zunächst einen akuten shRNA-basierten „knocked down“ von 
UNC 13A. Wir fügten das Knockdown-Konstrukt in der zweiten Phase des neu 
entwickelten Protokolls hinzu, d.h. nur 14 Tage vor der experimentellen 
Analyse in den autaptischen Kulturen. Wir zeigten, dass der Verlust von 




generierten wir eine humane Stammzelllinie, die für Syt1 defizient ist, 
kombiniert mit der lentiviralen Reinduzierung von Syt1. Mit diesem Ansatz 
testeten wir die Sensitivität unseres Protokolls für die Erzeugung humaner 
neuronaler autaptischer Kulturen durch die Untersuchung der synaptischen 
Übertragung im Vergleich zu dem bekannten Effekt in Mausmodellen. Wir 
konnten zeigen, dass der durch den Verlust des Syt1-Proteins verursachte 
Phänotyp dem Mausmodell ähnlich war und durch die erneute Einbringung 
des Syt1-Proteins wiederhergestellt werden konnte. Diese Ergebnisse 
belegen die Zuverlässigkeit als Modellsystem für weitere Experimente. 
Wir sind der Meinung, dass das humane autaptische iN-Kultursystem 
eine vielseitige Plattform bietet, die eine quantitative und qualitative Bewertung 
der morphologischen und physiologischen Parameter ermöglicht, die der 
humanen synaptischen Übertragung zugrunde liegen. Darüber hinaus kann es 
entscheidende Informationen über entwicklungsbiologische und funktionell 
bedingte Synaptopathien liefern, von denen man annimmt, dass sie viele 
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